Trial Profile
Apixaban Versus Warfarin in Patients With Advanced Chronic Kidney Disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Jul 2018
Price :
$35
*
At a glance
- Drugs Apixaban (Primary) ; Warfarin (Primary)
- Indications Venous thromboembolism
- Focus Adverse reactions; Therapeutic Use
- 03 Jul 2018 New trial record
- 01 Jun 2018 Results published in the Annals of Pharmacotherapy